Note to shareholders, this appointee is a specialist :
"She practiced as a corporate finance lawyer for over 15 years acting on takeovers, mergers and acquisitions,"
With increased M&A activity we believe SBM may be a takeover target.
Background*
Mrs. Kerry J. Gleeson, LLB(Hons) served as General Counsel and Company Secretary for Incitec Pivot Limited, a subsidiary of Incitec Ltd., since February 16, 2004 until October 31, 2013. Prior to IncitecPivot, Mrs. Gleeson has extensive board and senior management experience, having worked both nationally and internationally across several industries including chemicals, mining, agriculture, manufacturing and logistics., while practising in Australia, with Blake Dawson, and prior to that, as a partner of an English law firm. She practiced as a corporate finance lawyer for over 15 years acting on takeovers, mergers and acquisitions, IPOs and equity raisings in Australia, the UK and the US. She has been Non-Executive Director of McAleese Limited since September 2014. She a senior executive with Incitec Pivot Limited, an Australian-based global chemical and explosives company where she was a member of the Group Executive Team for almost a decade. She qualified as a lawyer in 1991, in England & Wales, and subsequently in Victoria, Australia in 2001. In 2009, She received the ALB Australasian Law Award for In-House Lawyer of the Year.
- Forums
- ASX - By Stock
- SBM
- SBM....potential takeover target?
SBM
st barbara limited
Add to My Watchlist
1.72%
!
28.5¢

SBM....potential takeover target?
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $308.6M |
Open | High | Low | Value | Volume |
29.0¢ | 29.5¢ | 28.0¢ | $2.028M | 7.071M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 1069835 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 271064 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1049835 | 0.280 |
9 | 1058518 | 0.275 |
14 | 326002 | 0.270 |
2 | 120000 | 0.265 |
1 | 400000 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 271064 | 5 |
0.295 | 1114119 | 13 |
0.300 | 877812 | 19 |
0.305 | 423542 | 8 |
0.310 | 879403 | 10 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SBM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online